"Pharmaceuticals - Top 5 Emerging Markets Industry Guide" now available at Fast Market Research

Recently published research from MarketLine, "Pharmaceuticals - Top 5 Emerging Markets Industry Guide", is now available at Fast Market Research
By: Fast Market Research, Inc.
 
April 18, 2012 - PRLog -- Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
* Includes a five-year forecast of the industry

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/343980_pharmaceuticals_top_5_e...
------------------------------------------------------------

Highlights

The top 5 emerging countries contributed $84,411.9 million to the global pharmaceuticals industry in 2010, with a compound annual growth rate (CAGR) of 14.9% between 2006 and 2010.

The top 5 emerging countries are expected to reach a value of $157,090.7 million in 2015, with a CAGR of 13.2% over the 2010-15 period.

Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $43,133 million in 2010.

The China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $90,201.5 million in 2015.

Why you should buy this report

* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs for in-patient and out-patient usage, valued at ex-manufacturer prices. All currency conversions in this profile were carried out using constant 2010 average annual exchange rates.

Partial Table of Contents:

TABLE OF CONTENTS
ABOUT DATAMONITOR
INTRODUCTION
What is this report about?
Who is the target reader?
Market Definition
TOP 5 EMERGING COUNTRIES PHARMACEUTICALS INDUSTRY OUTLOOK
PHARMACEUTICALS IN BRAZIL
Market Overview
Market Value
Market Segmentation
Market Share
Five Forces Analysis
Leading Companies
Market Forecasts
Macroeconomic Indicators
PHARMACEUTICALS IN CHINA
Market Overview
Market Value
Market Segmentation
Market Share
Five Forces Analysis
Leading Companies
Market Forecasts
Macroeconomic Indicators
PHARMACEUTICALS IN INDIA
Market Overview
Market Value
Market Segmentation
Market Share
Five Forces Analysis
Leading Companies
Market Forecasts
Macroeconomic Indicators
PHARMACEUTICALS IN MEXICO
Market Overview
Market Value
Market Segmentation
Market Share
Five Forces Analysis
Leading Companies
Market Forecasts
Macroeconomic Indicators
PHARMACEUTICALS IN SOUTH AFRICA
Market Overview
Market Value
Market Share
Five Forces Analysis
Leading Companies
Market Forecasts
Macroeconomic Indicators
APPENDIX
Data Research Methodology
About Datamonitor
Disclaimer

LIST OF TABLES
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2006-15
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($m), 2006-10
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($m), 2010-15
Table 4: Brazil pharmaceuticals market value: $ million, 2006-10
Table 5: Brazil pharmaceuticals market segmentation: % share, by value, 2010
Table 6: Brazil pharmaceuticals market share: % share, by value, 2010
Table 7: GlaxoSmithKline Plc: key facts
Table 8: GlaxoSmithKline Plc: key financials ($)
Table 9: GlaxoSmithKline Plc: key financials (GBP)
Table 10: GlaxoSmithKline Plc: key financial ratios
Table 11: Grupo EMS Sigma Pharma: key facts
Table 12: Novartis AG: key facts
Table 13: Novartis AG: key financials ($)
Table 14: Novartis AG: key financial ratios
Table 15: Brazil pharmaceuticals market value forecast: $ million, 2010-15
Table 16: Brazil size of population (million), 2006-10
Table 17: Brazil gdp (constant 2000 prices, $ billion), 2006-10
Table 18: Brazil gdp (current prices, $ billion), 2006-10
Table 19: Brazil inflation, 2006-10
Table 20: Brazil consumer price index (absolute), 2006-10
Table 21: Brazil exchange rate, 2006-10
Table 22: China pharmaceuticals market value: $ million, 2006-10
Table 23: China pharmaceuticals market segmentation: % share, by value, 2010
Table 24: China pharmaceuticals market share: % share, by value, 2010
Table 25: AstraZeneca PLC: key facts
Table 26: AstraZeneca PLC: key financials ($)
Table 27: AstraZeneca PLC: key financial ratios
Table 28: Pfizer Inc.: key facts
Table 29: Pfizer Inc.: key financials ($)
Table 30: Pfizer Inc.: key financial ratios
Table 31: Yangtze River Pharmaceutical Group: key facts
Table 32: China pharmaceuticals market value forecast: $ million, 2010-15
Table 33: China size of population (million), 2006-10
Table 34: China gdp (constant 2000 prices, $ billion), 2006-10
Table 35: China gdp (current prices, $ billion), 2006-10
Table 36: China inflation, 2006-10
Table 37: China consumer price index (absolute), 2006-10
Table 38: China exchange rate, 2006-10
Table 39: India pharmaceuticals market value: $ million, 2006-10
Table 40: India pharmaceuticals market segmentation: % share, by value, 2010
Table 41: India pharmaceuticals market share: % share, by value, 2010
Table 42: Cipla Ltd: key facts
Table 43: GlaxoSmithKline Plc: key facts
Table 44: GlaxoSmithKline Plc: key financials ($)
Table 45: GlaxoSmithKline Plc: key financials (GBP)
Table 46: GlaxoSmithKline Plc: key financial ratios
Table 47: Piramal Healthcare Limited: key facts
Table 48: Piramal Healthcare Limited: key financials ($)
Table 49: Piramal Healthcare Limited: key financials (Rs.)
Table 50: Piramal Healthcare Limited: key financial ratios
Table 51: India pharmaceuticals market value forecast: $ million, 2010-15

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=3439...

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information.  View more research from MarketLine at http://www.fastmr.com/catalog/publishers.aspx?pubid=1034

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source:Fast Market Research, Inc.
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Pharmaceutical, 2006-10, Glaxosmithkline, Pharmaceuticals, Pfizer, 2010-15, Liabilities, Assets, Piramal, Healthcare
Industry:Medical
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share